FCMI
LRMR icon

Foresite Capital Management III’s Larimar Therapeutics LRMR Stock Holding History

Foresite Capital Management III’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,508
Closed -$822K – 24
2017
Q2 		$822K Sell
19,508
-11,398
-37% -$583K 0.27% 21
2017
Q1 		$1.73M Sell
30,906
-8,211
-21% -$408K 0.66% 21
2016
Q4 		$1.49M Sell
39,117
-5,674
-13% -$230K 0.65% 15
2016
Q3 		$1.78M Hold
44,791
– – 0.83% 11
2016
Q2 		$3.22M Sell
44,791
-42,779
-49% -$3.38M 2.21% 10
2016
Q1 		$7.02M Sell
87,570
-4,072
-4% -$321K 5.43% 5
2015
Q4 		$6.92M Buy
+91,642
New +$14.7M 6.54% 5

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return